Self-dissolving microneedles for the percutaneous absorption of EPO in mice

Journal of Drug Targeting

Volumn 14, Issue 5, 2006, Pages 255-261

  Ito, Yukako ^a   Yoshimitsu, Jun Ichiro ^a   Shiroyama, Keiji ^a   Sugioka, Nobuyuki ^a   Takada, Kanji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

EPO; Mice; Microneedle; Percutaneous absorption

Indexed keywords

ALBUMIN; CHONDROITIN SULFATE; DEXTRIN; POLYMER; POLYPROPYLENE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SKIN ABSORPTION;

ALBUMINS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHONDROITIN SULFATES; DEXTRINS; ERYTHROPOIETIN; MALE; MICE; SKIN ABSORPTION;

EID: 33746809493     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860600785080     Document Type: Article

References (44)

1. Abels, R. (1993) Erythropoietin for anaemia in cancer patients Eur J Cancer, 29A(Suppl 2), pp. S2-S8.
2. Ambrose, CG and Clanto, TO. (2004) Bioabsorbable implants: Review of clinical experience in orthopedic surgery Ann Biomed Eng, 32(1), pp. 171-177.
3. Amino, Y and Kawada, K and Toi, K and Kumashiro, I and Fukushima, K. (1988) Phenylalanine derivatives enhancing intestinal absorption of EPO in mice Chem Pharm Bull, 36, pp. 4426-4434.
4. Barry, B and Williams, A. (2003) Penetration enhancers Adv Drug Deliv Rev, 56, pp. 603-618.
5. Bleuel, H and Hoffman, R and Kaufman, B and Neubert, P and Ochlich, PP and Schaumann, W. (1996) Kinetics of subcutaneous versus intravenous epoetin-beta in dogs, rats and mice Pharmacology, 52, pp. 329-338.
6. Case, DC, Jr and Bukowski, RM and Carey, RW and et al. (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy J Natl Cancer Inst, 85, pp. 801-806.
7. Cevc, G. (2004) Lipid vesicles and other colloids as drug carriers on the skin Adv Drug Deliv Rev, 56, pp. 675-711.
8. Chandrasekaran, S and Brazzle, JD and Frazier, AB. (2003) Surface micromachined metallic microneedles J Microelectromech Syst, 12(3), pp. 281-288.
9. Cunha, AS and Grossiord, JL and Puisieux, F and Seiller, M. (1997) EPO in W/O/W multiple emulsions: Biological activity after oral administration in normal and diabetic rats J Microencapsul, 14, pp. 321-333.
10. Davis, JM and Aralkawas, T and Strickland, TW and Yphantis, DA. (1987) Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells Biochemistry, 26, pp. 2633-2638.
11. Demetri, GD and Kris, M and Wade, J and Degos, L and Cella, D. (1998) Quality-of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Result from a prospective community oncology study J Clin Oncol, 16, pp. 3412-3425.
12. Doukas, A. (2004) Transdermal delivery with a pressure wave Adv Drug Deliv Rev, 56, pp. 559-579.
13. Eschbach, JW and Egrie, JC and Downing, MR and Browne, JK and Adamson, JW. (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin N Engl J Med, 316, pp. 73-78.
14. Goldwasser, E and Kung, CHK. (1968) Progress in the purification of erythropoietin Ann N Y Acad Sci, 149, pp. 49-53.
15. Graspy, J and Bukowski, R and Steinberg, D and Taylor, C and Tchekmedyian, S and Vadhan-Raj, S. (1997) Impact of therapy with wpowtin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice J Clin Oncol, 15, pp. 1218-1234.
16. Griss, P and Enoksson, P and Stemme, G. (2002) Micromachined barbed spikes for mechanical chip attachment Sens Acutuators A Phys, 95, pp. 94-99.
17. Kim, K and Park, DS and Lu, HM and Che, W and Kim, K and Lee, JB and Ahn, CH. (2004) A tapered hollow metallic microneedle array using backside exposure of SU-8 J Micromech Microeng, 14, pp. 597-603.
18. Leitgeb, C and Pecherstorfer, M and Fritz, E and Ludwig, H. (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin Cancer, 73, pp. 2535-2542.
19. Littlewood, TJ and Bajetta, E and Nortier, JWR and Vercammen, E and Rapoport, B. (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized double-blind, placebo-controlled trial J Clin Oncol, 19, pp. 2865-2874.
20. Ludwig, H and Fritz, E and Kotzmann, H and Höcker, P and Gisslinger, H and Barnas, U. (1990) Erythropoietin treatment of anemia associated with multiple myeloma N Engl J Med, 322, pp. 1693-1699.
21. Ludwig, H and Sundal, E and Pecherstorfer, M and et al. (1995) Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytoxic chemotherapy Cancer, 76, pp. 2319-2329.
22. Maitani, Y and Hazama, M and Tojo, Y and Simoda, N and Nagai, T. (1996) Oral administration of recombinant human erythropoietin in liposomes in rats: Influence of lipid composition and size of liposomes on bioavailability J Pharm Sci, 85(4), pp. 440-445.
23. Maitani, Y and Moriya, H and Shimoda, N and Takayama, K and Nagai, T. (1999) Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats Int J Pharm, 185, pp. 13-22.
24. Markham, A and Bryson, H. (1995) Epoetin alfa, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in non-renal applications Drugs, 49(2), pp. 232-254.
25. Matsuzawa, A and Morishita, M and Takayama, K and Nagai, T. (1995) Absorption of EPO using water-in-oil-in-water emulsion from an enteral loop in rats Biol Pharm Bull, 18, pp. 1718-1723.
26. McLennan, DNM and Porter, CJH and Edwards, GA and Martin, SW and Heatherington, AC and Charman, SA. (2005) Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep J Pharmacol Exp Ther, 313, pp. 345-351.
27. Mitragotri, S and Kost, J. (2004) Low-frequency sonophoresis: A review Adv Drug Deliv Rev, 56, pp. 589-601.
28. Miyano, T and Tobinaga, Y and Kanno, T and Matsuzaki, Y and Takeda, H and Wakui, M and Hanada, K. (2005) Sugar micro needles as transdermic drug delivery system Biomed Microdevices, 7, pp. 185-188.
29. Mizuno, A and Ueda, M and Kawanishi, G. (1992) Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats J Pharm Pharmacol, 44, pp. 570-573.
30. Morishita, I and Morishita, M and Takayama, K and Machida, Y and Nagai, T. (1992) Hypoglycemic effect of novel oral microspheres of EPO with protease inhibitor in normal and diabetic rats Int J Pharm, 78, pp. 9-16.
31. Morishita, M and Morishita, I and Takayama, K and Machida, Y and Nagai, T. (1993) Site dependent effect of aprotinin, sodium caprate Na2EDTA and sodium glycocholate on intestinal absorption of EPO Biol Pharm Bull, 16, pp. 68-72.
32. Morishita, M and Matsuzawa, A and Takayama, K and Isowa, K and Nagai, T. (1998) Improving EPO enteral absorption using water-in-oil-in-water emulsion Int J Pharm, 172, pp. 189-198.
33. Prausnitz, MR. (2004) Microneedles for transdermal drug delivery Adv Drug Deliv Rev, 56, pp. 581-587.
34. Preat, V and Vanbever, R. (2004) Skin electroporation for transdermal and topical delivery Adv Drug Deliv Rev, 56, pp. 659-674.
35. Shimoda, N and Maitani, Y and Machida, Y and Nagai, T. (1995) Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats Biol Pharm Bull, 18(5), pp. 734-739.
36. Spivak, J. (1994) Recombinant human erythropoietin and the anaemia of cancer Blood, 84(4), pp. 997-1004.
37. Takeuchi, H and Yamamoto, H and Niwa, T and Hino, T and Kawashima, Y. (1996) Enteral absorption of EPO in rats from mucoadhesive Chitosan coated liposomes Pharm Res, 13, pp. 896-901.
38. Teo, MAL and Shearwood, C and Ng, KC and Lu, J and Moochhala, S. (2005) In vitro and in vivo characterization of MEMS microneedles Biomed Microdevices, 7(1), pp. 47-52.
39. Tozaki, H and Komoike, J and Tada, C and Maruyama, T and Terabe, A and Suzuki, J. (1997) Chitosan capsules for colon-specific drug delivery: Improvement of EPO absorption from the rat colon J Pharm Sci, 86, pp. 1016-1021.
40. Urabe, A and Takaku, T and Mizoguchi, H and Kubo, K and Ota, K and Shimizu, N and Tanaka, K and Miura, N and Nihei, H and Koshikawa, S and Akizawa, T and Akiyama, N and Otsubo, O and Kawaguchi, Y and Maeda, T. (1988) Effect of recombinant human erythropoietin on the anemia of chronic renal failure Int J Cell Cloning, 6, pp. 179-191.
41. Utoguchi, N and Watanabe, Y and Shida, T and Matsumoto, M. (1998) Nitric oxide donors enhance rectal absorption of macromolecules in rabbits Pharm Res, 15, pp. 870-876.
42. Winerals, CG and Olivar, DO and Pippard, MJ and Reid, C and Downing, MR and Cotes, PR. (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet ii, pp. 1175-1177.
43. Yamamoto, A and Taniguchi, T and Rikyuu, K and Tsuji, T and Murakami, M and Muranishi, S. (1994) Effects of various protease inhibitors on the intestinal absorption and degradation of EPO in rats Pharm Res, 11, pp. 1496-1500.
44. Zahn, JD and Talbot, NH and Pisano, AP and Liepman, D. (2000) Microfabricated polysilicon microneedles for minimally invasive biomedical devices Biomed Microdevices, 2(4), pp. 295-303.